These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 3386755)

  • 1. HIV-1 tat trans-activation requires the loop sequence within tar.
    Feng S; Holland EC
    Nature; 1988 Jul; 334(6178):165-7. PubMed ID: 3386755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tackling Tat.
    Karn J
    J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Kao SY; Calman AF; Luciw PA; Peterlin BM
    Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional but not translational regulation of HIV-1 by the tat gene product.
    Rice AP; Mathews MB
    Nature; 1988 Apr; 332(6164):551-3. PubMed ID: 2833703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription.
    Das AT; Harwig A; Vrolijk MM; Berkhout B
    J Virol; 2007 Jul; 81(14):7742-8. PubMed ID: 17494072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV trans-activation and transcription control mechanisms.
    Jones KA
    New Biol; 1989 Nov; 1(2):127-35. PubMed ID: 2562218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric human immunodeficiency virus type 1 TAR region which mediates high level trans-activation in both rodent and human cells.
    Newstein M; Lee IS; Venturini DS; Shank PR
    Virology; 1993 Dec; 197(2):825-8. PubMed ID: 7504372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.
    Taylor JP; Kundu M; Khalili K
    Virology; 1993 Aug; 195(2):780-5. PubMed ID: 8337844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z; Huq I; Rana TM
    Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
    Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
    Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
    Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
    J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-sequence-mediated gene regulation in HIV-1.
    Cullen BR
    Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
    Kanevsky I; Chaminade F; Ficheux D; Moumen A; Gorelick R; Negroni M; Darlix JL; Fossé P
    J Mol Biol; 2005 May; 348(5):1059-77. PubMed ID: 15854644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional significance of the dinucleotide bulge in stem-loop1 and stem-loop2 of HIV-2 TAR RNA.
    Rhim H; Rice AP
    Virology; 1994 Jul; 202(1):202-11. PubMed ID: 8009832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.